GMED (Globus Medical) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


GMED Globus Medical Inc GMED
97 GF Score
Price $84.65
GF Value $98.62
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Globus Medical Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Globus Medical's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

GMED vs PODD, PEN, MASI: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Globus Medical's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Globus Medical Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Globus Medical's Margin of Safety % (DCF Earnings Based) falls into.


GMED
97GF Score
Globus Medical Inc GMED
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Globus Medical (GMED) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of $84.65 is trading 14.2% below its estimated GF Value™ of $98.62. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for GMED:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $98.62 vs. price of $84.65 (14.2% below fair value)
  • GF Score™: 97/100 with 4 warning signs

No single metric tells the full story. See the GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Globus Medical Business Description

Other Exchanges GMED:MexicoGM0N:Germany
Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
97GF Score

Get the complete analysis for GMED

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$84.65
Price
$98.62
GF Value